These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37555752)

  • 41. Evaluation of existing and desired measures to monitor, prevent and control healthcare-associated infections in Swiss hospitals.
    Metsini A; Widmer A; Zingg W; Gardiol C; Vuichard-Gysin D; Eder M; Maag J; Schlegel M; Marschall J; Harbarth S; Sommerstein R;
    Swiss Med Wkly; 2021 Jul; 151():w20516. PubMed ID: 34265072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.
    Weiner LM; Fridkin SK; Aponte-Torres Z; Avery L; Coffin N; Dudeck MA; Edwards JR; Jernigan JA; Konnor R; Soe MM; Peterson K; McDonald LC
    MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(9):235-41. PubMed ID: 26963489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Health economic evaluation of an infection prevention and control program: are quality and patient safety programs worth the investment?
    Raschka S; Dempster L; Bryce E
    Am J Infect Control; 2013 Sep; 41(9):773-7. PubMed ID: 23993762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation.
    Thomas C; Brennan A; Goka E; Squires HY; Brenner G; Bagguley D; Buckley Woods H; Gillett M; Leaviss J; Clowes M; Heathcote L; Cooper K; Breeze P
    BMJ Open; 2020 Sep; 10(9):e037486. PubMed ID: 32912949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017.
    Weiner-Lastinger LM; Abner S; Edwards JR; Kallen AJ; Karlsson M; Magill SS; Pollock D; See I; Soe MM; Walters MS; Dudeck MA
    Infect Control Hosp Epidemiol; 2020 Jan; 41(1):1-18. PubMed ID: 31767041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased use of 6-monthly gonadotropin-releasing hormone agonist therapy for prostate cancer: a capacity and cost-minimization analysis for England.
    Cornford P; Halpin C; Sassmann J; Frankcom I; Braybrook S
    J Med Econ; 2023; 26(1):208-218. PubMed ID: 36749636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs.
    Umscheid CA; Mitchell MD; Doshi JA; Agarwal R; Williams K; Brennan PJ
    Infect Control Hosp Epidemiol; 2011 Feb; 32(2):101-14. PubMed ID: 21460463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A systematic review and meta-analysis of disease burden of healthcare-associated infections in China: an economic burden perspective from general hospitals.
    Liu X; Spencer A; Long Y; Greenhalgh C; Steeg S; Verma A
    J Hosp Infect; 2022 May; 123():1-11. PubMed ID: 35182684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Effect of 24/7, Digital-First, NHS Primary Care on Acute Hospital Spending: Retrospective Observational Analysis.
    Winward S; Patel T; Al-Saffar M; Noble M
    J Med Internet Res; 2021 Jul; 23(7):e24917. PubMed ID: 34292160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Point prevalence and risk factors of hospital acquired infections in a cluster of university-affiliated hospitals in Shiraz, Iran.
    Askarian M; Yadollahi M; Assadian O
    J Infect Public Health; 2012 Apr; 5(2):169-76. PubMed ID: 22541264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors and Outcomes of Healthcare-Associated Infections Caused by Carbapenem-Nonsusceptible Enterobacterales: A Parallel Matched Case-Control Study.
    Hoo GSR; Cai Y; Quek YC; Teo JQ; Choudhury S; Koh TH; Lim TP; Marimuthu K; Ng OT; Kwa AL
    Front Cell Infect Microbiol; 2022; 12():719421. PubMed ID: 35281438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health care-associated infections, including device-associated infections, and antimicrobial resistance in Iran: The national update for 2018.
    Masoudifar M; Gouya MM; Pezeshki Z; Eshrati B; Afhami S; Farzami MR; Seifi A
    J Prev Med Hyg; 2021 Dec; 62(4):E943-E949. PubMed ID: 35603257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Economic evaluations of whole-genome sequencing for pathogen identification in public health surveillance and health-care-associated infections: a systematic review.
    Tran M; Smurthwaite KS; Nghiem S; Cribb DM; Zahedi A; Ferdinand AD; Andersson P; Kirk MD; Glass K; Lancsar E;
    Lancet Microbe; 2023 Nov; 4(11):e953-e962. PubMed ID: 37683688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective surveillance of device-associated health care-associated infection in an intensive care unit of a tertiary care hospital in New Delhi, India.
    Kumar S; Sen P; Gaind R; Verma PK; Gupta P; Suri PR; Nagpal S; Rai AK
    Am J Infect Control; 2018 Feb; 46(2):202-206. PubMed ID: 29046215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of a new methodology and R package reveals a high burden of healthcare-associated infections (HAI) in Germany compared to the average in the European Union/European Economic Area, 2011 to 2012.
    Zacher B; Haller S; Willrich N; Walter J; Abu Sin M; Cassini A; Plachouras D; Suetens C; Behnke M; Gastmeier P; Wieler LH; Eckmanns T
    Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiology of healthcare-associated infections and mechanisms of antimicrobial resistance of responsible pathogens in Ukraine: a multicentre study.
    Salmanov A; Shchehlov D; Svyrydiuk O; Bortnik I; Mamonova M; Korniyenko S; Rud V; Artyomenko V; Gudym M; Maliarchuk R; Bondar T
    J Hosp Infect; 2023 Jan; 131():129-138. PubMed ID: 36306892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimating the economic cost of carbapenem resistant Enterobacterales healthcare associated infections in Singapore acute-care hospitals.
    Cai Y; Hoo GSR; Lee W; Tan BH; Yoong J; Teo YY; Graves N; Lye D; Kwa AL
    PLOS Glob Public Health; 2022; 2(12):e0001311. PubMed ID: 36962882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and Economic Outcomes of Genome Sequencing Availability on Containing a Hospital Outbreak of Resistant Escherichia coli in Australia.
    Lee XJ; Elliott TM; Harris PNA; Douglas J; Henderson B; Watson C; Paterson DL; Schofield DS; Graves N; Gordon LG
    Value Health; 2020 Aug; 23(8):994-1002. PubMed ID: 32828227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integration of genomic and clinical data augments surveillance of healthcare-acquired infections.
    Ward DV; Hoss AG; Kolde R; van Aggelen HC; Loving J; Smith SA; Mack DA; Kathirvel R; Halperin JA; Buell DJ; Wong BE; Ashworth JL; Fortunato-Habib MM; Xu L; Barton BA; Lazar P; Carmona JJ; Mathew J; Salgo IS; Gross BD; Ellison RT
    Infect Control Hosp Epidemiol; 2019 Jun; 40(6):649-655. PubMed ID: 31012399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.